Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

This study has been terminated.
(Difficulty finding subjects who met the inclusion/exclusion criteria.)
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00906035
First received: May 20, 2009
Last updated: January 31, 2013
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)